Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
137,892,346
-
Share change
-
-1,378,595
-
Total reported value
-
$7,277,629,308
-
Put/Call ratio
-
215%
-
Price per share
-
$52.77
-
Number of holders
-
260
-
Value change
-
-$74,014,437
-
Number of buys
-
131
-
Number of sells
-
114
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q4 2016
As of 31 Dec 2016,
SEATTLE GENETICS INC - COM (SGEN) was held by
260 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
137,892,346 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Fund Advisors, WASATCH ADVISORS INC, BlackRock Institutional Trust Company, N.A., and STATE STREET CORP.
This page lists
260
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.